OraSure Technologies (OSUR) Shares are Down -4.65%

OraSure Technologies (OSUR) has risen sharply, recording gains of 7.89% in the past 4 weeks. However, the stock has corrected -4.65% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 6.79% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The stock has recorded a 20-day Moving Average of 3.33% and the 50-Day Moving Average is 1.88%. OraSure Technologies (NASDAQ:OSUR): On Fridays trading session , Opening price of the stock was $7.05 with an intraday high of $7.13. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $6.92. However, the stock managed to close at $6.97, a loss of 1.13% for the day. On the previous day, the stock had closed at $7.05. The total traded volume of the day was 509,460 shares.


The company Insiders own 7.8% of OraSure Technologies shares according to the proxy statements. Institutional Investors own 80.84% of OraSure Technologies shares. Also, Major Brokerage house, Jefferies maintains its ratings on OraSure Technologies (NASDAQ:OSUR). In the latest research report, Jefferies lowers the target price from $8.5 per share to $8 per share. According to the latest information available, the shares are now rated Buy by the analysts at the agency. The rating by the firm was issued on August 4, 2016.

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.